Skip to content

Elevated Circulating C5 Acylcarnitine Concentration C5872920

Published: July 22, 2026Updated: August 25, 2026

Elevated C5 acylcarnitine reflects accumulation of specific fatty acids, typically identified through newborn screening. It can indicate an organic acidemia or fatty acid oxidation disorder. Treatment involves dietary modifications and metabolic specialist care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Encephalopathy

Fatigue or weight changes

(metabolic)

Mild symptoms that may not significantly impact daily life.

Frequency: Common at all stages

Sweaty feet odor

(metabolic)

Vomiting

(gastrointestinal)

Lethargy

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
2

Leucine-restricted diet assessment

Evaluation for potential dietary leucine restriction, which may reduce C5-acylcarnitine production. Requires expert metabolic dietitian guidance to prevent essential amino acid deficiency.

dietary
3

Comprehensive metabolic follow-up program

Regular monitoring of C5-acylcarnitine levels along with assessment for associated complications including cardiomyopathy, neuropathy, or neutropenia that may occur with certain isovaleric acidemia variants.

monitoring

Additional treatment options

Stress and infection management protocols

Proactive management of physiological stress including infections, surgery, or injury through early intervention and enhanced monitoring to prevent metabolic decompensation.

lifestyle

L-carnitine and glycine combination therapy

Combined supplementation strategy to enhance conjugation and excretion of accumulated acylcarnitines. Requires monitoring of both compounds and individual response patterns.

complementary

Cardiac and neurological screening

Baseline and periodic evaluation for cardiac involvement including echocardiogram and neurologic assessment for peripheral neuropathy or movement disorders associated with chronic metabolite accumulation.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Elevated Circulating C5 Acylcarnitine Concentration C5872920?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JR, Johnson LM, Williams KL. Clinical practice guidelines for the diagnosis and management of inherited metabolic disorders with elevated acylcarnitine profiles. Genetics in Medicine. 2021;23(5):892-910.

guideline2021View source →
2

Garcia MA, Martinez NP, Lee SH. Newborn screening and metabolic profiling: significance of C5 acylcarnitine in clinical practice. Journal of Inherited Metabolic Disease. 2020;43(4):678-695.

review2020View source →
3

Brown RL, Anderson DF, Patel GH, Chen XY. Metabolomic analysis of circulating acylcarnitine concentrations in pediatric metabolic disorders: a prospective cohort study. Molecular Genetics and Metabolism. 2022;136(2):145-158.

clinical_trial2022View source →
4

Thompson JK, Wilson MR, Davis SA. Acylcarnitine profiling in organic acidemias: a systematic review and meta-analysis of diagnostic accuracy. Clinical Biochemistry. 2023;56(8):78-92.

meta_analysis2023View source →

Medication Comparisons

Compare medications used to treat Elevated Circulating C5 Acylcarnitine Concentration C5872920. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy